221 related articles for article (PubMed ID: 26184857)
41. MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.
Seabrook A; Wijewardene A; De Sousa S; Wong T; Sheriff N; Gill AJ; Iyer R; Field M; Luxford C; Clifton-Bligh R; McCormack A; Tucker K
J Clin Endocrinol Metab; 2022 Jul; 107(8):2339-2349. PubMed ID: 35323929
[TBL] [Abstract][Full Text] [Related]
42. Multiple Endocrine Neoplasia: A Genetically Diverse Group of Familial Tumor Syndromes.
Pacheco MC
J Pediatr Genet; 2016 Jun; 5(2):89-97. PubMed ID: 27617149
[TBL] [Abstract][Full Text] [Related]
43. A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype.
Occhi G; Regazzo D; Trivellin G; Boaretto F; Ciato D; Bobisse S; Ferasin S; Cetani F; Pardi E; Korbonits M; Pellegata NS; Sidarovich V; Quattrone A; Opocher G; Mantero F; Scaroni C
PLoS Genet; 2013 Mar; 9(3):e1003350. PubMed ID: 23555276
[TBL] [Abstract][Full Text] [Related]
44. Pediatric head and neck manifestations associated with multiple endocrine neoplasia syndromes.
Jellins T; Hill M; Prager JD; Francom CR; Chan CM; Schneider KW; Sharma A; Herrmann BW
Int J Pediatr Otorhinolaryngol; 2023 Oct; 173():111703. PubMed ID: 37604101
[TBL] [Abstract][Full Text] [Related]
45. [Clinical genetics of neuroendocrine tumors].
Karges W; Adler G
Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
[TBL] [Abstract][Full Text] [Related]
46. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
[TBL] [Abstract][Full Text] [Related]
47. p27 variant and corticotropinoma susceptibility: a genetic and in vitro study.
Sekiya T; Bronstein MD; Benfini K; Longuini VC; Jallad RS; Machado MC; Goncalves TD; Osaki LH; Higashi L; Viana J; Kater C; Lee M; Molatore S; Francisco G; Chammas R; Naslavsky MS; Schlesinger D; Gama P; Duarte YA; Lebrão ML; Zatz M; Meirelles O; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
Endocr Relat Cancer; 2014 Jun; 21(3):395-404. PubMed ID: 24532476
[TBL] [Abstract][Full Text] [Related]
48. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.
Engelmann D; Koczan D; Ricken P; Rimpler U; Pahnke J; Li Z; Pützer BM
Endocr Relat Cancer; 2009 Mar; 16(1):211-24. PubMed ID: 18984779
[TBL] [Abstract][Full Text] [Related]
49. A patient with MEN1 typical features and MEN2-like features.
El-Maouche D; Welch J; Agarwal SK; Weinstein LS; Simonds WF; Marx SJ
Int J Endocr Oncol; 2016 May; 3(2):89-95. PubMed ID: 27594983
[TBL] [Abstract][Full Text] [Related]
50. The development of rapid and accurate screening test for RET hotspot somatic and germline mutations in MEN2 syndromes.
Zupan A; Glavač D
Exp Mol Pathol; 2015 Dec; 99(3):416-25. PubMed ID: 26321248
[TBL] [Abstract][Full Text] [Related]
51. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
52. Endocrine cancer syndromes: an update.
Anik A; Abaci A
Minerva Pediatr; 2014 Dec; 66(6):533-47. PubMed ID: 25243504
[TBL] [Abstract][Full Text] [Related]
53. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
[TBL] [Abstract][Full Text] [Related]
54. [Pathogenic patterns of genetic predisposition to endocrine tumors].
Calender A
Nephrol Ther; 2006 Jan; 2 Suppl 2():S127-36. PubMed ID: 17373213
[TBL] [Abstract][Full Text] [Related]
55. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
[TBL] [Abstract][Full Text] [Related]
56. MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics.
Schernthaner-Reiter MH; Trivellin G; Stratakis CA
Neuroendocrinology; 2016; 103(1):18-31. PubMed ID: 25592387
[TBL] [Abstract][Full Text] [Related]
57. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
[TBL] [Abstract][Full Text] [Related]
58. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
59. Genetic analysis of a Chinese Han family with multiple endocrine neoplasia type 2A.
Guo Y; Xu H; Ren Z; Yang Y; Xiong W; Gao K; Li X; Luo Z; Deng H
Indian J Biochem Biophys; 2013 Feb; 50(1):26-31. PubMed ID: 23617071
[TBL] [Abstract][Full Text] [Related]
60. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
